ATRQβ-001, a peptide vaccine made of human angiotensin II (AngII) receptor I and Qβ phage virus-like particles, can inhibit the Ang II-mediated pathway, thus being applied in the treatment of hypertension and aneurysms. The gene discussed is AGT; the disease is hypertensive disorder.